News
325 - 326 of 326 news items
Children born with a specific mutation of cystic fibrosis (CF) could see improvements in their condition if they have access to the oral drug therapy, Ivacaftor, earlier in life, according to research carried out at Royal Brompton Hospital.
Over 60 participants from more than 30 countries gathered at the Royal Society of Medicine and Royal Brompton and Harefield hospitals last month, for the start of the UK’s first postgraduate course